Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 10/20 | 0.54 |
| ▸ | WNT3 | P56703 | 2/20 | 0.45 |
| ▸ | SFRP1 | Q8N474 | 2/20 | 0.45 |
| ▸ | TACR3 | P29371 | 1/20 | 0.43 |
| ▸ | CETP | P11597 | 3/20 | 0.42 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4820251 | 1.00 | TACR1 (0.54) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL4820246 | 1.00 | TACR1 (0.54) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL5213787 | 1.00 | TACR1 (0.54) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL4821853 | 1.00 | TACR1 (0.54) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL13756728 | 0.96 | TACR1 (0.53) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL12809148 | 0.94 | TACR1 (0.53) | TACR1WNT3SFRP1TACR3CETP | |
| SCHEMBL5211643 | 0.90 | TACR1 (0.54) | TACR1TACR3CETP | |
| SCHEMBL5213007 | 0.90 | TACR1 (0.54) | TACR1TACR3CETP | |
| SCHEMBL13756722 | 0.89 | TACR1 (0.57) | TACR1TACR3CETP | |
| SCHEMBL12809094 | 0.88 | TACR1 (0.60) | TACR1TACR3CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1581517-B1 | SUBSTITUTED 1-PIPERIDIN-4-YL-4-AZETIDIN-3-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2007-02-21 | — | — | EP | claimed |